Keros Therapeutics
Latest round
- Series C
Last raised
- Mar 2020
Total raised
- $68M
Investors
- 10
About Keros Therapeutics
Based in Massachusetts, US, and founded in 2016, Keros Therapeutics, Inc. operates as a provider of therapies that modulate TGF-ß signaling for patients with conditions affecting blood cells, bone, skeletal muscle, adipose tissue, and heart tissues. progressive (FOP), which promotes the transformation of muscle into bone. In January 2024, Keros Therapeutics, Inc.5 million shares at USD 40 per share. The firm trades on NASDAQ under the ticker symbol KROS.D. The company provides a wide range of therapeutic products, such as KER-050 for ineffective hematopoiesis in myelodysplastic syndromes and myelofibrosis, KER-012 for pulmonary arterial hypertension, and KER-065 for obesity and neuromuscular diseases. Additionally, the firm also provides research services focused on developing new treatment options for diseases with unmet medical needs.
Who invested in Keros Therapeutics
10 investors across 2 rounds
See all investors in Keros Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Keros Therapeutics
Who invested in Keros Therapeutics?
Keros Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Keros Therapeutics raised?
Keros Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Keros Therapeutics last raise money?
Keros Therapeutics's most recent round on record is a Series C, in Mar 2020.
What does Keros Therapeutics do?
Based in Massachusetts, US, and founded in 2016, Keros Therapeutics, Inc.
Where is Keros Therapeutics headquartered?
Keros Therapeutics is headquartered in Lexington, US.
Which VCs invest in companies like Keros Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Keros Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Keros Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.